Author: Dr. Ahmed Turki Hani

Trigeminal Neuralgia (TN), historically known as tic douloureux, is a severe neuropathic disorder characterized by episodes of excruciating, intense facial pain. The condition involves the trigeminal nerve, the fifth (V) and largest cranial nerve, which transmits facial sensation to the brain. Because of the debilitating nature of the pain, TN is often tragically referred to as "the suicide disease."

Clinical Presentation and Triggers
The pain is unilateral and typically affects the maxillary (V2) or mandibular (V3) divisions. It is universally described as an abrupt, electric shock-like or stabbing sensation, lasting from a few seconds to two minutes. These paroxysmal attacks can occur repeatedly, severely impacting the patient's functional ability and quality of life.
A defining feature of TN is the presence of sensitive trigger zones. Attacks can be initiated by routine, mundane activities such as chewing, talking, smiling, brushing teeth, or even feeling a gentle breeze across the face.

Etiology and Pathophysiology
Trigeminal Neuralgia is broadly categorized by its cause:
- Classic Trigeminal Neuralgia (TN1): The overwhelming majority of cases are caused by the chronic compression of the trigeminal nerve root by an adjacent blood vessel (most often the superior cerebellar artery) as the nerve exits the brainstem. This chronic compression leads to demyelination (stripping of the protective myelin sheath), causing sensory signals to misfire and register as excruciating pain.
- Secondary Trigeminal Neuralgia (TN2): This less common form is caused by an underlying structural pathology, such as a tumor, cyst, or demyelinating diseases like multiple sclerosis (MS). These secondary causes often involve a component of persistent, aching background pain.

Management and Treatment
Treatment follows a tiered approach aimed at stabilizing the hyperexcitable nerve fibers:
1- Pharmacological Therapy: The first line of defense consists of anticonvulsant medications, primarily carbamazepine and oxcarbazepine. These drugs work by blocking sodium channels to dampen nerve activity.
2- Surgical Intervention: For patients refractory to medication, or who suffer from severe side effects, surgery is considered.
- Microvascular Decompression (MVD): This is the most definitive surgical option for TN. It involves physically relocating the offending blood vessel away from the nerve root using a Teflon pad. MVD offers the highest long-term success rate while preserving nerve function.
- Ablative Procedures: Less invasive options like radiofrequency thermocoagulation or Gamma Knife radiosurgery are used when MVD is contraindicated. These methods intentionally damage the nerve root to interrupt the pain signals, carrying a higher risk of permanent facial numbness.
Effective management is highly individualized, requiring collaboration between neurologists and neurosurgeons to provide TN sufferers with relief from the debilitating pain.


Al-Mustaqbal University – The Leading University in Iraq

Trigeminal Neuralgia